Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents

American Journal of Health-System Pharmacy

Volumn 66, Issue 11, 2009, Pages 986-987

  Newland, Ashley M ^a   Mauro, Vincent F ^b   Alexander, Kenneth S ^c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CARDIOVASCULAR AGENT; DILTIAZEM; EPTIFIBATIDE; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; LEPIRUDIN; LIDOCAINE; METOPROLOL TARTRATE; MILRINONE; NESIRITIDE; NITROPRUSSIDE SODIUM; PHENYTOIN; PROCAINAMIDE;

CONCENTRATION (PARAMETERS); CONTINUOUS INFUSION; DRUG BIOAVAILABILITY; HEART INFARCTION; HYPERTENSION; LETTER; PH; PRECIPITATION; PRIORITY JOURNAL;

EID: 66949130340     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080002     Document Type: Letter

References (3)

1. Antman EM, Hand M, Armstrong PW et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2008; 117:296-329. [Erratum, Circulation. 2008; 117:e162.]
2. Trissel LA. Handbook of injectable drugs. 15th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2009:1080.
3. Metoprolol tartrate injection prescribing information. Bedford, OH: Bedford Laboratories; 2005 Aug.